• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

microRNA 表达谱鉴定慢性淋巴细胞白血病细胞中的活化 B 细胞状态。

MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.

机构信息

Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2011 Mar 8;6(3):e16956. doi: 10.1371/journal.pone.0016956.

DOI:10.1371/journal.pone.0016956
PMID:21408091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3050979/
Abstract

Chronic lymphocytic leukemia (CLL) is thought to be a disease of resting lymphocytes. However, recent data suggest that CLL cells may more closely resemble activated B cells. Using microRNA (miRNA) expression profiling of highly-enriched CLL cells from 38 patients and 9 untransformed B cells from normal donors before acute CpG activation and 5 matched B cells after acute CpG activation, we demonstrate an activated B cell status for CLL. Gene set enrichment analysis (GSEA) identified statistically-significant similarities in miRNA expression between activated B cells and CLL cells including upregulation of miR-34a, miR-155, and miR-342-3p and downregulation of miR-103, miR-181a and miR-181b. Additionally, decreased levels of two CLL signature miRNAs miR-29c and miR-223 are associated with ZAP70(+) and IgV(H) unmutated status and with shorter time to first therapy. These data indicate an activated B cell status for CLL cells and suggest that the direction of change of individual miRNAs may predict clinical course in CLL.

摘要

慢性淋巴细胞白血病(CLL)被认为是静止淋巴细胞的疾病。然而,最近的数据表明,CLL 细胞可能更类似于活化的 B 细胞。我们使用来自 38 名患者和 9 名正常供体未经急性 CpG 激活的未转化 B 细胞以及 5 个匹配的急性 CpG 激活后的 B 细胞的高度富集的 CLL 细胞的 microRNA(miRNA)表达谱,证明了 CLL 的活化 B 细胞状态。基因集富集分析(GSEA)在激活的 B 细胞和 CLL 细胞之间的 miRNA 表达中发现了统计学上显著的相似性,包括 miR-34a、miR-155 和 miR-342-3p 的上调以及 miR-103、miR-181a 和 miR-181b 的下调。此外,两种 CLL 特征 miRNA miR-29c 和 miR-223 的水平降低与 ZAP70(+)和 IgV(H)未突变状态以及首次治疗时间较短有关。这些数据表明 CLL 细胞具有活化的 B 细胞状态,并表明单个 miRNA 的变化方向可能预测 CLL 的临床病程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/c3a7fae50e1c/pone.0016956.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/6fac225070ef/pone.0016956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/237f31ab0036/pone.0016956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/35ac1630a96a/pone.0016956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/c3a7fae50e1c/pone.0016956.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/6fac225070ef/pone.0016956.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/237f31ab0036/pone.0016956.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/35ac1630a96a/pone.0016956.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e983/3050979/c3a7fae50e1c/pone.0016956.g004.jpg

相似文献

1
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.microRNA 表达谱鉴定慢性淋巴细胞白血病细胞中的活化 B 细胞状态。
PLoS One. 2011 Mar 8;6(3):e16956. doi: 10.1371/journal.pone.0016956.
2
miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.miR-181a/b 通过靶向多个抗凋亡基因显著增强慢性淋巴细胞白血病细胞对药物的敏感性。
Carcinogenesis. 2012 Jul;33(7):1294-301. doi: 10.1093/carcin/bgs179. Epub 2012 May 18.
3
miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.miR-34a 和 miR-29b 作为中国维吾尔族和汉族慢性淋巴细胞白血病患者无治疗生存预后的标志物。
Mol Cell Probes. 2019 Oct;47:101436. doi: 10.1016/j.mcp.2019.101436. Epub 2019 Aug 16.
4
Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.依鲁替尼可下调一部分微小RNA,导致慢性淋巴细胞白血病中肿瘤抑制因子上调并抑制细胞增殖。
Leukemia. 2017 Feb;31(2):340-349. doi: 10.1038/leu.2016.181. Epub 2016 Jun 24.
5
Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.白细胞介素21调控CD40激活的慢性淋巴细胞白血病细胞中的mRNA和微小RNA表达。
PLoS One. 2015 Aug 25;10(8):e0134706. doi: 10.1371/journal.pone.0134706. eCollection 2015.
6
MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia.慢性淋巴细胞白血病合并自身免疫性溶血性贫血中 microRNA 的表达。
Leuk Lymphoma. 2013 Sep;54(9):2016-22. doi: 10.3109/10428194.2012.763123. Epub 2013 Jan 29.
7
CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.CLL 细胞对 B 细胞受体刺激的反应表现出与 MYC 激活和细胞周期进程相关的 microRNA/mRNA 特征。
PLoS One. 2013;8(4):e60275. doi: 10.1371/journal.pone.0060275. Epub 2013 Apr 1.
8
Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.中国慢性淋巴细胞白血病患者异常的 microRNA 表达。
Leuk Res. 2011 Jun;35(6):730-4. doi: 10.1016/j.leukres.2010.11.005. Epub 2010 Dec 3.
9
Karyotype-specific microRNA signature in chronic lymphocytic leukemia.慢性淋巴细胞白血病中特定核型的微小RNA特征
Blood. 2009 Oct 29;114(18):3872-9. doi: 10.1182/blood-2009-06-229211. Epub 2009 Aug 28.
10
microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.miRNA-34a 的表达与慢性淋巴细胞白血病中 MDM2 SNP309 多态性和无治疗生存相关。
Blood. 2010 May 27;115(21):4191-7. doi: 10.1182/blood-2009-07-234823. Epub 2010 Jan 20.

引用本文的文献

1
MicroRNA changes with macro potential contribute to secondary immunodeficiency in chronic lymphocytic leukemia during epstein barr virus reactivation.微小RNA变化与宏观潜能共同促成慢性淋巴细胞白血病在爱泼斯坦-巴尔病毒重新激活期间的继发性免疫缺陷。
Sci Rep. 2025 May 12;15(1):16446. doi: 10.1038/s41598-025-01572-4.
2
Multiple omics levels of chronic lymphocytic leukemia.慢性淋巴细胞白血病的多组学水平
Cell Death Discov. 2024 Jun 21;10(1):293. doi: 10.1038/s41420-024-02068-2.
3
Role of microRNAs in Chronic Lymphocytic Leukemia.微小 RNA 在慢性淋巴细胞白血病中的作用。

本文引用的文献

1
Identification of the human mature B cell miRNome.人类成熟B细胞微小RNA组的鉴定。
Immunity. 2009 May;30(5):744-52. doi: 10.1016/j.immuni.2009.03.017. Epub 2009 May 14.
2
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.微小RNA 15a和16调节多发性骨髓瘤中的肿瘤增殖。
Blood. 2009 Jun 25;113(26):6669-80. doi: 10.1182/blood-2009-01-198408. Epub 2009 Apr 28.
3
MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.慢性淋巴细胞白血病发病机制及疾病亚型中的微小RNA
Int J Mol Sci. 2023 Aug 5;24(15):12471. doi: 10.3390/ijms241512471.
4
Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.血浆 miR-29a 评估在慢性淋巴细胞白血病患者中的预后价值。
Asian Pac J Cancer Prev. 2023 Jul 1;24(7):2439-2444. doi: 10.31557/APJCP.2023.24.7.2439.
5
Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases.miR-150在B淋巴细胞相关疾病中的多种功能及调控网络
Front Oncol. 2023 Apr 27;13:1140813. doi: 10.3389/fonc.2023.1140813. eCollection 2023.
6
miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12.miR-342-3p 通过靶向 SOX12 抑制急性髓系白血病进展。
Oxid Med Cell Longev. 2022 Sep 8;2022:1275141. doi: 10.1155/2022/1275141. eCollection 2022.
7
TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.转化生长因子-β/信号转导分子 Mothers Against Decapentaplegic(SMAD)信号通路受微小RNA-26b-5p(miR-26b-5p)调控:慢性淋巴细胞白血病进展谜题中的又一环节
Cancers (Basel). 2022 Mar 25;14(7):1676. doi: 10.3390/cancers14071676.
8
Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia.B 细胞慢性淋巴细胞白血病患者血浆中 mir-15b、mir-195 及肿瘤抑制基因 DLEU7 的表达变化
Rep Biochem Mol Biol. 2021 Apr;10(1):20-29. doi: 10.52547/rbmb.10.1.20.
9
Interphase fluorescence in situ hybridization analysis of CD19-selected cells: Utility in detecting disease in post-therapy samples of B-cell neoplasms.间期荧光原位杂交分析 CD19 选择的细胞:在 B 细胞肿瘤治疗后样本中检测疾病的应用。
Cancer Med. 2021 Apr;10(8):2680-2689. doi: 10.1002/cam4.3853. Epub 2021 Mar 15.
10
Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe.非编码RNA:慢性淋巴细胞白血病领域的“暗物质”
Pharmaceuticals (Basel). 2021 Feb 21;14(2):168. doi: 10.3390/ph14020168.
Leuk Lymphoma. 2009 Mar;50(3):506-9. doi: 10.1080/10428190902763517.
4
Patterns of microRNA expression characterize stages of human B-cell differentiation.微小RNA表达模式表征人类B细胞分化阶段。
Blood. 2009 May 7;113(19):4586-94. doi: 10.1182/blood-2008-09-178186. Epub 2009 Feb 6.
5
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities.在伴有TP53异常的慢性淋巴细胞白血病(CLL)患者中,miR-34a、miR-29c和miR-17-5p表达下调。
Leukemia. 2009 Jun;23(6):1159-63. doi: 10.1038/leu.2008.377. Epub 2009 Jan 22.
6
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification.微小RNA-29c和微小RNA-223的下调在慢性淋巴细胞白血病中具有体内意义,并改善疾病风险分层。
Blood. 2009 May 21;113(21):5237-45. doi: 10.1182/blood-2008-11-189407. Epub 2009 Jan 14.
7
miR-181b negatively regulates activation-induced cytidine deaminase in B cells.微小RNA-181b对B细胞中激活诱导的胞嘧啶脱氨酶起负向调节作用。
J Exp Med. 2008 Sep 29;205(10):2199-206. doi: 10.1084/jem.20080579. Epub 2008 Sep 1.
8
The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.核因子-κB亚基Rel A与慢性淋巴细胞白血病的体外存活及临床疾病进展相关,是一个有前景的治疗靶点。
Blood. 2008 May 1;111(9):4681-9. doi: 10.1182/blood-2007-11-125278. Epub 2008 Jan 28.
9
ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.在慢性淋巴细胞白血病中,ZAP-70增强IgM信号传导,且与其激酶活性无关。
Blood. 2008 Mar 1;111(5):2685-92. doi: 10.1182/blood-2006-12-062265. Epub 2007 Nov 29.
10
B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element.B细胞受体激活通过保守的AP-1元件诱导BIC/miR-155表达。
J Biol Chem. 2008 Feb 1;283(5):2654-62. doi: 10.1074/jbc.M708218200. Epub 2007 Nov 28.